US plans to cut billions in healthcare funding present an 'opportunity' for UAE, says CEO
Trump administration plans to scale back billions in government funding for healthcare, research, and disease control and prevention, represent both a challenge and opportunity for the UAE, says the CEO of Abu Dhabi's M42.
'Whatever is not being done in the US, we will do it here in Abu Dhabi,' Hasan Jasem al-Nowais told Al Arabiya's Hadley Gamble on Wednesday at the Abu Dhabi Global Health Week.
The message comes as the Trump administration looks to enact sweeping reforms of US government-backed health agencies. Moves that have already caused concern amongst global health experts who fear downsizing could impact the fight against disease and the prevention of future pandemics.
According to reports, $40 billion, or one-third of the US Department of Health and Human Services (HHS) discretionary budget, National Institutes of Health (NIH) funding would be cut by $20 billion in 2026, a 40 percent reduction overall, with 27 current divisions absorbed into 8, and 4 eliminated completely.
But even while acknowledging the cuts, the CEO and President of Cleveland Clinic, USA, pushed back on claims that the President is defunding the NIH.
'It's not defunding the NIH,' Dr. Tom Mihaljevic told Gamble. '[Right now], for every dollar used for research areas, there's 60 percent of overhead. And this has been in place for such a long time that nobody ever questioned it.' he said.
Speaking alongside al-Nowais in Abu Dhabi, Mihaljevic sought to downplay the real world impact the administration's proposals might have, framing the move as an attempt by the White House to cut out wasteful spending.
'I think there is a reasonable case to be made about how… we allocate the research dollars, and can we use them more efficiently. Do we really need to use 60 percent overhead for every dollar that is issued? I think that's a legitimate question.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
3 days ago
- Al Arabiya
‘The Second Brain': Why gut health is the key to mental clarity, wellbeing
The gut's influence extends far beyond digestion – affecting everything from immunity and inflammation to focus, mood, and mental clarity. This interconnectedness is driving a wave of innovation in personalized health, and at the center of it is Bioniq, a supplement company using data to turn gut health into a foundation for mental and physical performance. The importance of gut health 'Gut health has become a focal point in personalized health because it's now widely understood that the gut plays a central role in overall well-being – it affects everything from immunity and energy levels to mental health and inflammation. It's often called the 'second brain' for a reason,' said Oliver Motisi, Chief Product Officer at Bioniq, in an interview with Al Arabiya English. Trillions of bacteria live in the human digestive tract, forming the gut microbiome. These microbes influence hormone production, metabolize nutrients, regulate immune cells, and even produce up to 95 percent of the body's serotonin – one of the brain's key mood stabilizers. When the gut microbiome is imbalanced, inflammation can rise and communication between the brain and body can break down. 'At Bioniq, we don't look at gut health in isolation. Instead, we integrate it into a broader, data-driven understanding of each individual's biology,' Motisi said. 'Our approach is grounded in blood biomarker analysis, so if we see signs of inflammation, nutrient malabsorption or deficiencies linked to gut function, that's where we start.' The gut-brain axis Each personalized supplement formula is designed with precision and built on a prebiotic fiber base to support both nutrient absorption and microbiome diversity. 'Our goal is to support the body as a whole, with gut health as a critical part of the full system, guided by real data, not guesswork.' The company is especially focused on the bidirectional communication between the gut and brain – what scientists call the gut-brain axis. This channel involves the central and enteric nervous systems and uses neural, hormonal and immune signals to send constant updates between the two organs. 'We now know that changes in gut microbiota can significantly impact cognitive performance, mood and emotional resilience,' Motisi explained. 'That's because the gut and brain are deeply interconnected through the gut-brain axis – a communication pathway that includes neural, hormonal and immune signals.' Mental health symptoms like brain fog, anxiety, and fatigue are often early signs of imbalances in the gut. When the balance of bacteria in the gut is disturbed, it can interfere with the production and signaling of brain chemicals such as serotonin, dopamine and gamma-aminobutyric acid (GABA). For example, low levels of beneficial gut bacteria may reduce serotonin production, which can contribute to anxiety or low mood. Imbalances can also trigger low-grade inflammation, which has been linked to cognitive issues like brain fog and difficulty concentrating. Fatigue may result from poor nutrient absorption in the gut, especially when the body lacks key vitamins and minerals like B12, magnesium or iron. In some cases, individuals with irritable bowel syndrome (IBS) or other digestive conditions also report increased symptoms of stress, anxiety or depression – highlighting how gut health and mental health are often very much intertwined. Micronutrients Micronutrients play a major role in gut-brain health, Motisi explained. 'Micronutrients play a foundational role in how our brains function – they're the building blocks behind everything from memory and focus to mood and resilience,' he said. 'Take magnesium, for example – it's essential for neurotransmitter function and managing stress. Elements like zinc and selenium support processes related to mental clarity and immune health.' Tailored ingredients To address these imbalances that people may have, Bioniq creates custom supplement blends with ingredients tailored to target brain and body together. 'When it comes to cognitive function, that can mean including targeted ingredients like magnesium, omega-3s, adaptogens, and more to help boost clarity, focus, and mental performance.' What sets Bioniq apart in a crowded supplement market is its deep reliance on data. 'Since our founding in 2019, Bioniq has built one of the largest databases of its kind, drawing from over 300,000 individuals and more than 6 million biochemical data points,' Motisi said. 'Our patented algorithm cross-references users' health quiz responses with real-world blood test results to create a truly personalized formulation.' Looking ahead, Motisi sees blood-based biomarkers – particularly those linked to inflammation – reshaping how brain and mental health are tracked and treated. 'I believe the future of brain health will be increasingly defined by how we interpret inflammatory markers, hormonal balance, and metabolic health together, rather than in isolation.' For conditions like anxiety or even neurodegenerative diseases, Motisi said he sees tremendous promise. 'By tailoring supplementation based on an individual's specific biomarkers, we can target these root causes more precisely,' he said.
Al Arabiya
4 days ago
- Al Arabiya
US-backed Gaza aid group appoints evangelical pastor as new chairman
The Gaza Humanitarian Foundation (GHF) on Tuesday appointed an evangelical pastor with close ties to US President Donald Trump as its new leader. Reverend Dr. Johnnie Moore was announced as the executive chairman following the recent resignation of Jake Wood last weekend, GHF announced in a statement. Wood said GHF was not following 'humanitarian principles.' Moore was previously appointed by President Trump as a Commissioner on the US Commission for International Religious Freedom (USCIRF). 'GHF is demonstrating that it is possible to move vast quantities of food to people who need it most—safely, efficiently, and effectively. I am honored to bring my experience to bear to help scale this vital mission and ensure the humanitarian aid community and the broader international community understand what's taking place on the ground,' he said in a statement. He said GHF believes that serving Gazans 'with dignity and compassion must be the top priority' and welcomed others to join the effort. The UN and other aid groups have criticized GHF, but Moore said false reporting of violence at the aid sites in Gaza has 'a chilling effect on the local population, and we can think of no greater disservice to a community in dire need.' At least 27 Palestinians were killed and dozens wounded by Israeli fire near a food distribution site in the southern Gaza Strip on Tuesday, local health authorities said, in the third day of chaos and bloodshed to affect the aid operation. The Israeli military said its forces had opened fire on a group of individuals who had left designated access routes near the distribution center in Rafah. On June 1, some 32 people were killed and on Monday three people were killed, according to the UN. The US-backed Gaza Humanitarian Foundation launched its first distribution sites last week in an effort to alleviate widespread hunger amongst Gaza's war-battered population, most of whom have had to abandon their homes to flee fighting. The foundation's aid plan, which bypasses traditional aid groups, has come under fierce criticism from the United Nations and established charities which say it does not follow humanitarian principles. The private group, which is endorsed by Israel, said it distributed 21 truckloads of food early on Tuesday and that the aid operation was 'conducted safely and without incident within the site.'
Al Arabiya
6 days ago
- Al Arabiya
‘I am not taking drugs!' Elon Musk denies media report
Elon Musk on Saturday denied a report that he used ketamine and other drugs extensively last year on the 2024 campaign trail. The New York Times reported Friday that the billionaire adviser to President Donald Trump used so much ketamine, a powerful anesthetic, that he developed bladder problems. The newspaper said the world's richest person also took ecstasy and mushrooms and traveled with a pill box last year, adding that it was not known whether Musk also took drugs while heading the so-called Department of Government Efficiency (DOGE) after Trump took power in January. In a post Saturday on X, Musk said: 'To be clear, I am NOT taking drugs! The New York Times was lying their ass off.' He added: 'I tried 'prescription' ketamine a few years ago and said so on X, so this not even news. It helps for getting out of dark mental holes, but haven't taken it since then.' Musk first dodged a question about his drug use at a bizarre farewell appearance Friday with Trump in the Oval Office in which the Tesla and SpaceX boss sported a noticeable black eye as he formally ended his role as Trump's main cost-cutter at DOGE, which fired tens of thousands of civil servants. News of the injury drew substantial attention as it came right after the Times report on his alleged drug use. The daily recalled erratic behavior such as Musk giving an enthusiastic Nazi-style salute in January of this year at a rally celebrating Trump's inauguration. Musk said he got the injury while horsing around with his young son, named X, when he told the child to hit him in the face. 'And he did. Turns out even a five-year-old punching you in the face actually is...' he added, before tailing off. Later Friday, when a reporter asked Trump if he was aware of Musk's 'regular drug use,' Trump responded: 'I wasn't.' 'I think Elon is a fantastic guy,' he added. Musk has previously admitted to taking ketamine, saying he was prescribed it to treat a 'negative frame of mind' and suggesting his use of drugs benefited his work.
